Digestive & Intestinal Remedies (Pharmacies) - Southeast Asia

Southeast Asia

Highlights

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$959.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.34%, resulting in a market volume of US$1.25bn by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$1.39 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestive & Intestinal Remedies (Pharmacies) market in Southeast Asia is experiencing significant growth and development.

Customer preferences: Customers in Southeast Asia have shown a growing preference for digestive and intestinal remedies in recent years. This can be attributed to several factors, including changing lifestyles, increasing stress levels, and a rise in gastrointestinal disorders. As people in the region become more aware of the importance of digestive health, they are seeking out products that can alleviate symptoms and promote overall well-being.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Southeast Asia is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic medications and are turning to alternative solutions. This has led to a rise in the popularity of traditional remedies, such as herbal teas, probiotics, and digestive enzymes. Additionally, there is a growing trend towards preventive care, with consumers seeking products that can support their digestive health on a daily basis. Another notable trend is the emergence of e-commerce as a major distribution channel for digestive and intestinal remedies. Online platforms provide consumers with a convenient and accessible way to purchase these products, especially in rural areas where access to physical pharmacies may be limited. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increase in online shopping across all sectors.

Local special circumstances: Each country in Southeast Asia has its own unique set of circumstances that influence the development of the Digestive & Intestinal Remedies market. For example, in countries like Thailand and Indonesia, traditional medicine and herbal remedies have long been a part of the culture, and this has shaped consumer preferences. In contrast, countries like Singapore and Malaysia have a more Westernized healthcare system, which has led to a greater reliance on pharmaceutical products.

Underlying macroeconomic factors: The growing middle class in Southeast Asia is a key driver of the Digestive & Intestinal Remedies market. As disposable incomes rise, consumers are willing to spend more on healthcare products, including those that target digestive health. Additionally, urbanization and the increasing prevalence of sedentary lifestyles have contributed to a rise in gastrointestinal disorders, further boosting demand for these remedies. Furthermore, the region's aging population is also a significant factor in the market's development. As people age, they are more likely to experience digestive issues and seek out remedies to alleviate symptoms. This demographic trend is expected to continue in the coming years, driving further growth in the Digestive & Intestinal Remedies market. In conclusion, the Digestive & Intestinal Remedies market in Southeast Asia is experiencing growth and development due to changing customer preferences, including a preference for natural remedies, the emergence of e-commerce as a distribution channel, and local special circumstances such as cultural influences. Underlying macroeconomic factors, such as the growing middle class and aging population, also contribute to the market's growth.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.